Researchers identified toll-like receptor (TLR) signaling as a novel pathway regulating GLI3 expression, which plays a role in inflammatory cytokine production and cancer. They found that IRF3 directly binds to the GLI3 promoter region, increasing its expression upon TLR4 stimulation.
SLFN11 acts as a surveillance factor for protein homeostasis by alleviating proteotoxic stress derived from protein synthesis and maturation. Its lack makes cells vulnerable to anticancer drugs inducing ER and proteotoxic stress, leading to chemoresistance. SLFN11 is also involved in regulating immune response and inflammation.
Researchers investigated the effects of neoadjuvant chemoradiotherapy on CD8+ tumor-infiltrating lymphocytes, PD-L1, and mucin expression in rectal cancer patients. The study found that nCRT exposure was associated with higher mucin expression and a non-significant difference in PD-L1 expression, suggesting an immunosuppressive phenotype.
A new study introduces a novel epigenetic predictor, PCBrainAge, that captures aging heterogeneity across multiple brain regions. The tool demonstrates stronger associations with AD dementia and pathologic AD compared to existing age predictors.
A new study found that HIV-1 Tat expression accelerates age-related diseases in male mice by disrupting neuroendocrine function. Researchers discovered that Tat alters steroid hormone levels, leading to anxiety-like behavior, cognitive errors, and reduced grip strength.
Researchers identified CUDC907 as a dual phosphoinositide-3 kinase/histone deacetylase inhibitor that promotes apoptosis in NF2 schwannoma cells. The compound reduced viability and induced cell cycle arrest in human merlin deficient Schwann cell models.
A new study uses machine learning models to predict cancer patients' responses to immunotherapy based on their gut microbiome features. The research identifies common gut bacterial taxa associated with responders versus non-responders, providing a potential tool for distinguishing and predicting immunotherapy responders.
Researchers found associations between perceived discrimination and epigenetic aging in US middle-aged and older adults. Depressive symptoms were identified as a potential mediator in these relationships, particularly among women and White adults.
Researchers analyzed germline variants in breast cancer patients to identify their role in metastasis development. The study found that host genetic makeup contributes to metastasis through dysregulation of gene expression, promoting the dispersion of metastatic seeds and establishing a conducive environment for their growth.
Abemaciclib, a CDK4 & 6 inhibitor, showed profound inhibition of cell proliferation and triggered senescence and apoptosis in breast cancer cells. Continuous dosing provided sustained inhibition with irreversible effects through apoptosis, supporting the differentiated safety and efficacy profile.
Researchers found global redistribution of histone H3 modifications with time, particularly in intergenic regions and near transcription start sites. Caloric restriction diet feeding reduced the extent of changes occurring during the first year of life in these genomic regions.
This volume of Oncotarget features groundbreaking research on various cancers, including breast, lung, colorectal, and neuroblastoma, as well as novel drug targets for bladder cancer. The studies also delve into the role of BRCA in breast and colorectal cancers.
A recent study published in Aging-US reveals the crucial role of WRN in making choices between classical and alternative non-homologous end joining (NHEJ) DNA repair pathways. The research provides new insights into progeroid syndromes, such as Werner syndrome, and their connection to aging.
Researchers identified DNA damage-inducible transcript 4 (DDIT4) as a critical factor regulated by histone deacetylase 4 (HDAC4) in skin aging. Overexpression of HDAC4 rescued cells from senescence, while DDIT4 overexpression reversed changes associated with aging.
A recent study identified 34 novel genes that contribute to endocrine resistance in breast cancer using dynamic gene expression analysis. The researchers found that these genes are differentially expressed in both estrogen receptor-positive and triple-negative breast cancers, suggesting shared genetic mechanisms underlying resistance d...
Researchers investigated the effects of treatment with exogenous Humanin G on inflammation markers in AMD and normal retinal cells. The study found reduced levels of inflammatory proteins in AMD plasma and treated cybrids, highlighting the positive effects of Humanin G.
Research suggests that NF-κB over-activation is associated with improved outcomes in patients with HPV-positive head and neck cancer. An RNA-based classifier trained on tumors with specific mutations may improve prognostic classification, aiding in treatment personalization.
Researchers developed CancerOmicsNet, a graph neural network model that integrates multiple heterogeneous data to predict cancer cell growth rate after drug treatment. The model achieved significantly higher cross-validated accuracy than other approaches on the same data.
The article proposes a new framework for understanding the hallmarks of cancer and aging, highlighting their shared underlying principles. Dr. Blagosklonny's hyperfunction theory arranges these hallmarks in a hierarchical structure, revealing common signaling pathways involved in both aging and cancer.
Researchers studied naked mole-rats' skin using single-cell RNA-seq to understand its remarkable stability against aging. They found no changes in epidermal gene expression with age and a unique keratinocyte differentiation trajectory that remained intact.
Dr. Blagosklonny discusses the potential of combining rapamycin with other modalities to live long enough to benefit from future discoveries in cellular reprogramming. He emphasizes that Altos Labs needs to develop rapamycin-based drug combinations to achieve additional decades of life extension, potentially within 3-5 years.
Impact Journals will participate as an exhibitor at the American Association for Cancer Research (AACR) 2022 annual meeting, showcasing their prominent journals Oncotarget and Aging (Aging-US). The conference focuses on Decoding Cancer Complexity | Integrating Science | Transforming Patient Outcomes.
Researchers discovered chemerin, a multifunctional protein, has antitumoral properties in mouse models of cancer. Bioactive chemerin overexpression inhibits neoangiogenesis, a process distinct from normal tissue vasculature. This effect may provide a therapeutic application for targeting solid tumors.
Researchers found that dysregulation of enzymes in the glucuronidation pathway is associated with castration-resistant prostate cancer. The study suggests that reducing UGDH expression and/or activity can reverse castration resistance, potentially preventing or delaying therapeutic resistance.
This study reveals cellular composition changes in colon organoids exposed to smoking and red/processed meat carcinogens, suggesting an overlap between inherited and environmental CRC risk. The findings provide novel insights into CRC etiology and reveal potential avenues for future research.
Researchers developed nanoTCEs to target AML cells, showing high specificity and potency in treating the disease. The technology uses nanoparticles to bind to CD33, a marker present on AML cells.
This study found high expression of Myosin 1g in pediatric acute lymphoblastic leukemia, suggesting its potential role in disease pathogenesis, particularly in high-risk patients. The research also showed that Myo1g may serve as a biomarker for identifying patients with an increased risk of relapse.
Research suggests that iron is a key factor in aging, causing cellular damage and organ deterioration. By blocking iron absorption, people may be able to extend their lifespan.
Researchers found that green tea catechins EGCG and ECG enhance fitness and lifespan in C. elegans by inhibiting complex I activity, reducing fat content and enhancing antioxidant defenses. This study provides evidence for the potential health benefits of green tea consumption in extending human lifespan.
Researchers use 103 retired sled dogs to study aging-related diseases like arthritis and cancer. The study aims to characterize canine aging mechanisms and identify biomarkers for anti-aging treatments.
This study found that aerobic exercise enhances doxorubicin's ability to kill cancer cells while minimizing its toxic effects on the heart. In addition, exercise has been shown to reduce the risk of breast cancer recurrence and improve quality-of-life parameters in cancer patients.
Researchers created a novel humanized mouse model to study hyperprogressive disease (HPD) and hyperprogression (HP) in mismatch repair-deficient colon cancer. The study found accelerated tumor growth after PD-1 blockade with pembrolizumab administration, and identified changes in human cytokine profiles.
Researchers discovered melatonin's antitumor effects in gallbladder cancer cells, promoting ROS-mediated apoptosis and suppressing the PI3K/Akt/mTOR signaling pathway. The study suggests melatonin as a potential novel candidate for gallbladder cancer treatment.
A meta-analysis of case-control and cohort studies found no causal link between H. pylori infection and Alzheimer's disease dementia, but may be associated with all-cause dementia. The study suggests future research on the pathogenic mechanism may lead to novel therapies.
A study published in Oncotarget found that hypertension and irregular medication use were independent risk factors for postoperative delirium after maxillofacial tumors radical surgery. The incidence of postoperative delirium was 41% in the hypertension group, compared to 12% in the non-hypertension group.
A positive correlation was found between MET gene amplification and PD-L1 expression in patients with NSCLC and no other actionable oncogenic driver. The study suggests that MET amplification up-regulates PD-L1 expression, which may impact treatment strategies for these patients.
The study applies deductive reasoning and particle physics principles to establish a common framework for aging research. This framework could benefit the field by providing a shared understanding of aging's complex processes, allowing researchers to design longevity interventions.
Researchers analyzed comprehensive metabolomic data to identify metabolic profiles distinguishing sarcopenia from frailty. The study found 22 sarcopenia markers that are largely distinct from 15 frailty markers, suggesting a shared metabolic basis for these two age-related diseases.
Researchers found that combining selinexor with olaparib induces robust anti-tumor activity in vitro and in vivo in triple negative breast cancer cell lines. The combination therapy overcomes the poor prognosis associated with TNBC, characterized by low disease-free and overall survival rates.
Hyperbaric oxygen therapy alleviated cognitive dysfunction, improved cerebral blood flow, and reduced amyloid burden in Alzheimer's disease models. In elderly patients with significant memory loss, HBOT showed an increase in cerebral blood flow and improvement in cognitive performance, demonstrating its therapeutic effects.
Trials that met their primary endpoint were more commonly published in journals with higher impact factors, suggesting a correlation between trial outcome and publication quality. Additionally, publications of trials leading to FDA approvals and those in high-impact journals were associated with increased Research Citation Rates.
Aging-US review highlights cerebrovascular dysfunctions as a core feature of AD, contributing to pathogenesis and progression. Adrenergic system modulation may serve as a key approach to modulate these abnormalities.
Research found that Pim kinase inhibitor co-treatment decreases alternative non-homologous end-joining DNA repair and genomic instability induced by topoisomerase 2 inhibitors in AML cells with FLT3-ITD. This approach may enhance chemotherapy drug induction of DNA DSBs and apoptosis.
Researchers found that inhibiting the MAP2K7-JNK pathway with 5Z-7-oxozeaenol induces apoptosis in T-cell acute lymphoblastic leukemia. The study used murine models and human patient-derived xenografts to evaluate the anti-leukemic capacity of 5Z7O, which showed synergistic induction of cytotoxicity when combined with dexamethasone.
Recent findings highlight the prevalence of cerebrovascular disorders in AD patients and suggest that cerebral vascular alterations contribute to pathogenesis. The adrenergic system may serve as a key approach to modulate these abnormalities and progressive neurodegeneration.
A study found that plasma cell-free miR-181c and tissue expression of miR-21, -210 accurately diagnose pancreatic adenocarcinoma (PA) with high accuracy. Further research is needed to validate its utility as a biomarker for PA diagnosis and monitoring.
A study published in Oncotarget identified four genetic variants linked to an increased risk of sporadic colorectal adenocarcinoma in the Kazakhstani population. The findings suggest that these variants, including rs10506868, may contribute to CRC development and highlight the importance of understanding genetic factors in this disease.
Researchers found that TAK1-inhibitors NG25 and 5Z-7 reduce the viability of multiple myeloma cell lines and primary cells, inducing apoptosis through various mechanisms. The combination of TAK1 inhibitors with DNA-damaging agents increases cytotoxicity in a synergistic or additive manner.
High BRCA1 mRNA levels in breast cancer correlate with better survival, while LMNB2's role in CRC reveals conflicting results. Young CRC patients exhibit low p21 expression, suggesting a link between BRCA1 mRNA and tumor progression.
A nationwide survey of Australian medical oncologists found that most were confident consenting patients for genomic profiling, but less confident discussing secondary germline findings. The study suggests that understanding oncologists' perspectives is crucial to integrating genomic profiling into routine care.